Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCIHirotoshi Watanabe, Takenori Domei, Takeshi Morimoto et al.|JAMA|2019Cited by 830
JCS 2020 Guideline Focused Update on Antithrombotic Therapy in Patients With Coronary Artery DiseaseMasato Nakamura, Atsushi Hirayama, Kazuo Kimura et al.|Circulation Journal|2020Cited by 345
The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular DiseaseHyun Kuk Kim, Young‐Hoon Jeong, Udaya S. Tantry et al.|Thrombosis and Haemostasis|2020Cited by 334
Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary SyndromeHirotoshi Watanabe, Motoaki Higuchi, Takeshi Morimoto et al.|JAMA Cardiology|2022Cited by 296
Ticagrelor vs. Clopidogrel in Japanese, Korean and Taiwanese Patients With Acute Coronary Syndrome – Randomized, Double-Blind, Phase III PHILO Study –Shinya Goto, Takeshi Kimura, Chien‐Hua Huang et al.|Circulation Journal|2015Cited by 280